Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
- 15 March 1991
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 114 (6) , 464-469
- https://doi.org/10.7326/0003-4819-114-6-464
Abstract
To explore the role of endothelin-1, a potent endothelial-derived vasoconstrictor peptide, in pulmonary hypertension, by measuring its concentration in arterial and venous plasma. A survey, case series study. University-affiliated hospitals and outpatient clinics. Twenty-seven patients with pulmonary hypertension: 7 with primary, and 20 with secondary pulmonary hypertension of various causes. The control groups (n = 16) comprised 8 healthy volunteers and 8 patients with coronary artery disease but without evidence of pulmonary hypertension. Pulmonary artery pressure was markedly increased (94/43 +/- 23/13 mm Hg) in the patients with pulmonary hypertension. Venous plasma immunoreactive endothelin-1, measured by a specific radioimmunoassay, was significantly higher in patients with pulmonary hypertension (3.5 +/- 2.5 pg/mL, P less than 0.001) than in normal subjects (1.45 +/- 0.45 pg/mL), or patients with coronary disease (0.75 +/- 0.64 pg/mL). The arterial-to-venous ratio of immunoreactive endothelin-1 was significantly greater than unity in primary pulmonary hypertension (2.21 +/- 0.72, P = 0.01), whereas the patients with secondary pulmonary hypertension had a mean ratio not different from 1 (0.97 +/- 0.42). In contrast, the mean arterial-to-venous ratios were significantly less than unity in both control groups (0.59 +/- 0.35, and 0.54 +/- 0.64; P less than 0.02, for normal subjects and coronary disease patients, respectively), indicating a possible clearance of endothelin-1 across the healthy lung. Patient with pulmonary hypertension have substantial alterations in plasma immunoreactive endothelin-1, which may reflect changes in net release or clearance of endothelin-1 by the lung. In patients with primary pulmonary hypertension, the high levels in arterial compared with venous plasma suggest pulmonary production of endothelin-1, which may contribute to elevated pulmonary vascular resistance.Keywords
This publication has 30 references indexed in Scilit:
- Tissue distribution and half-life of 125 I-endothelin in the rat: Importance of pulmonary clearanceBiochemical and Biophysical Research Communications, 1990
- Primary pulmonary hypertension: A look at the futureJournal of the American College of Cardiology, 1989
- Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassayBiochemical and Biophysical Research Communications, 1989
- Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shockBiochemical and Biophysical Research Communications, 1989
- Endothelin-1 and Endothelin-3 Release EDRF from Isolated Perfused Arterial Vessels of the Rat and RabbitJournal of Cardiovascular Pharmacology, 1989
- Endothelin-1 Releases Eicosanoids from Rabbit Isolated Perfused Kidney and SpleenJournal of Cardiovascular Pharmacology, 1989
- The Fate of Radioiodinated Endothelin-1 and Endothelin-3 in the RatJournal of Cardiovascular Pharmacology, 1989
- Effect of Endothelin-1 on Blood Pressure and Bronchopulmonary System of the Guinea PigJournal of Cardiovascular Pharmacology, 1989
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- The Pathology of Hypertensive Pulmonary Vascular DiseaseCirculation, 1958